Weiss Multi-Strategy Advisers’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-42,176
Closed -$1.66M – 784
2023
Q2
$1.66M Buy
+42,176
New +$1.49M 0.03% 495
2016
Q4
– Sell
-11,000
Closed -$507K – 537
2016
Q3
$507K Buy
11,000
+65
+0.6% +$3.67K 0.03% 344
2016
Q2
$558K Buy
+10,935
New +$543K 0.04% 314

Weiss Multi-Strategy Advisers's ISEE Position: Q3 2023 in Review

Weiss Multi-Strategy Advisers sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 42,176 shares — an estimated $1.66M sold.

Weiss Multi-Strategy Advisers first reported a position in ISEE in Q2 2016 and held it in 3 quarters. The position peaked at $1.66M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Weiss Multi-Strategy Advisers reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 42,176 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $1.66M.
  • Weiss Multi-Strategy Advisers first reported a position in IVERIC bio, Inc. Common Stock in Q2 2016 and held it in 3 quarters.
  • Weiss Multi-Strategy Advisers's IVERIC bio, Inc. Common Stock position peaked at $1.66M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.